|
ZNF563 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.95879999997928E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.561530E-02 |
| Normal-vs-Stage2 |
1.623910E-02 |
| Normal-vs-Stage3 |
1.3194999537447E-09 |
| Normal-vs-Stage4 |
6.34990000025759E-07 |
| Stage1-vs-Stage2 |
2.454800E-01 |
| Stage1-vs-Stage3 |
1.33840000005048E-06 |
| Stage1-vs-Stage4 |
6.372900E-04 |
| Stage2-vs-Stage3 |
1.895770E-01 |
| Stage2-vs-Stage4 |
2.654600E-01 |
| Stage3-vs-Stage4 |
8.910000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.67109999999116E-06 |
| Normal-vs-AfricanAmerican |
1.924380E-03 |
| Normal-vs-Asian |
2.202400E-01 |
| Caucasian-vs-AfricanAmerican |
4.549600E-01 |
| Caucasian-vs-Asian |
7.363400E-01 |
| AfricanAmerican-vs-Asian |
5.790200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.61651999999179E-05 |
| Normal-vs-Female |
5.62179999999968E-05 |
| Male-vs-Female |
9.334600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.335700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.997520E-04 |
| Normal-vs-Age(61-80Yrs) |
1.66170000004406E-06 |
| Normal-vs-Age(81-100Yrs) |
1.192250E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.012400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.339800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.642800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.008200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.998000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.702000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.606200E-01 |
| Normal-vs-Grade 2 |
9.143600E-03 |
| Normal-vs-Grade 3 |
2.39059999995739E-06 |
| Normal-vs-Grade 4 |
1.27929999926835E-09 |
| Grade 1-vs-Grade 2 |
3.287000E-01 |
| Grade 1-vs-Grade 3 |
1.441950E-01 |
| Grade 1-vs-Grade 4 |
2.457800E-02 |
| Grade 2-vs-Grade 3 |
2.431800E-02 |
| Grade 2-vs-Grade 4 |
3.61660000003372E-06 |
| Grade 3-vs-Grade 4 |
1.797540E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.083600E-02 |
| Normal-vs-ccB subtype |
3.78949982504651E-10 |
| ccA subtype-vs-ccB subtype |
1.08679999999417E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.25820000049937E-07 |
| Normal-vs-N1 |
3.244800E-03 |
| N0-vs-N1 |
1.006790E-01 |
|
|
